• Alexander D Makatsariya, Jamilya Khizroeva, and Viktoriya O Bitsadze.
• Correspondent Member of the Russian Academy of Sciences, Head of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty of I.M. Sechenov First Moscow State Medical University, Vice-President of Russian Association of Obstetricians and Gynaecologists, Dmitrii Ulyanov Street 4-2-432, 119333 Moscow, Russia, Tel.: +7(903)728-0897.
• J Perinat Med. 2018 May 24; 46 (4): 387-400.

BackgroundCatastrophic antiphospholipid syndrome (CAPS) is an uncommon, often fatal, variant of the antiphospholipid syndrome (APS) that results in a widespread coagulopathy and high titres of antiphospholipid antibodies (aPL) and affects predominantly small vessels supplying organs with the development of multiorgan failure. It remains unclear why some patients develop the typical clinical picture of APS (thrombosis of large vessels), whereas others show the development of progressive microthrombosis, which the authors called "thrombotic storm" and multiple organ failure, that is, CAPS.Materials And MethodsSince 2001-2016, we discovered 17 patients with CAPS development.ConclusionCAPS is life-threatening condition, but optimal treatment for CAPS is not developed yet and the mortality rate is as high as 30%-40%.

14 keywords...

hide…